Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adrenal Insufficiency × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 5 Multiple Myeloma 3 Lung Neoplasms 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Tuberous Sclerosis 2 Thoracic Neoplasms 2 Stomach Neoplasms 2 Skin Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Myasthenia Gravis 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hypertension 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Warts 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Diseases 1 Urinary Bladder Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Neoplasms 1 Thoracic Diseases 1

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡